TACR1 and neoplasm: GBM cells form an autocrine loop in which neuronal or tumour-derived SP engages NK1-R to activate ERK1/2 and PI3K–Akt, culminating in β-arrestin-1 recruitment, cyclin‐dependent kinase activation and accelerated cell-cycle transit.